United States · Biometrics startup
United States · Aptevo Therapeutics
Aptevo Therapeutics is a biotech company primarily focused on bringing novel oncology and hematology therapeutics to market.
Funding reportedLast round: Post ipo equity
What company datasets say Aptevo Therapeutics raised
Funding, as reported
Reported in all$57Min dollars
Rounds5
Last roundPost ipo equity
Last round dateJun 2024
SEC Form D$5.6M sold, 2 filings, last Aug 2026
On a portfolio page
Investors who name them
Each firm lists Aptevo Therapeutics on its own website. That is the firm's claim, a weaker thing than a round we watched, but a named source.
Biometrics in United States
Startups like it
Is this your company?
Add your raise, your deck and your story, and put Aptevo Therapeutics in front of investors. Or tell us what we have wrong.